News Report says US biotech needs $15bn support to fend off China The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.
R&D The time is right for a grand resurgence of commercial clini... In the dark days of 2020, amid the global race for a COVID-19 vaccine, the UK showcased its world-class expertise in medical research.
News BIO rings alarm bells over Trump's pharma tariffs US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.
News AZ builds in China, as J&J ramps up its US investments AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D Sponsored Reinventing R&D in the age of AI - How intelligent technolog... Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human
News Novo Nordisk fight with KBP Bio will go to arbitration Singapore court keeps an asset freeze on KBP Bio, saying the merits of its dispute with Novo Nordisk over a licensing deal must go to arbitration.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.